Cencora, Inc. vs Lana Medical Co.
A head-to-head of Cencora, Inc. (COR) and Lana Medical Co. (9587) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | COR | 9587 |
|---|---|---|
| Market Cap | $59.91B | 149.04M SAR |
| P/E (TTM) | 23.61 | 52.47 |
| Forward P/E | 13.46 | — |
| P/S | 0.16 | 1.61 |
| P/B | 25.62 | 2.17 |
| EV/EBITDA | 12.24 | 16.90 |
| Dividend Yield | 0.50% | — |
| Profit Margin | 0.78% | 2.92% |
| Gross Margin | 3.57% | 22.58% |
| Operating Margin | 1.22% | 7.45% |
| Revenue Growth (YoY) | +3.85% | -11.60% |
| FCF Yield | 3.01% | — |
| Debt / Equity | 345.49 | 31.02 |
| Current Ratio | 0.95 | 1.58 |
Which is better: Cencora, Inc. or Lana Medical Co.?
- ✓Larger by market cap: Cencora, Inc.
- ✓Cheaper valuation (lower P/E): Cencora, Inc.
- ✓More profitable (net margin): Lana Medical Co.
- ✓Faster revenue growth: Cencora, Inc.
Across 10 available metrics, Lana Medical Co. leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.